Colston K W, Feldman D
J Clin Endocrinol Metab. 1979 Nov;49(5):798-800. doi: 10.1210/jcem-49-5-798.
Isolated mouse renal tubule cells have been employed to demonstrate the presence of a specific high affinity cytoplasmic binding protein for 1,25-dihydroxycholecalciferol (1,25(OH)2D3) in kidney. This receptor-like macromolecule sedimented at 3.2 S in hypertonic sucrose density gradients. Scatchard analysis of [3H]1,25-(OH)2D3 binding at O C revealed an apparent Kd of 0.2 nM and a concentration of binding sites of 50 fmol/mg cytosol protein. In competition experiments, the binder exhibited a low affinity for other vitamin D3 metabolites; the order of potency was 1,25(OH)2D3 greater than 250HD3 greater than u alpha OHD3 greater than 24R,25(OH)2D3. The sedimentation properties, binding affinity, and specificity of this 1,25(OH)2D3 binding protein are strikingly similar to the receptors in rat intestine, mouse bone, and human intestine. The demonstration of a renal receptor-like binder adds further support to the concept that the kidney is a 1,25(OH)2D3 target organ.
分离的小鼠肾小管细胞已被用于证明肾脏中存在一种针对1,25 - 二羟胆钙化醇(1,25(OH)2D3)的特异性高亲和力细胞质结合蛋白。这种受体样大分子在高渗蔗糖密度梯度中以3.2 S沉降。在0℃下对[3H]1,25-(OH)2D3结合进行Scatchard分析,结果显示其表观解离常数(Kd)为0.2 nM,结合位点浓度为50 fmol/mg细胞质蛋白。在竞争实验中,该结合蛋白对其他维生素D3代谢产物表现出低亲和力;其活性顺序为1,25(OH)2D3>25 - 羟胆钙化醇(25OHD3)>α - 骨化醇(α OHD3)>24R,25(OH)2D3。这种1,25(OH)2D3结合蛋白的沉降特性、结合亲和力和特异性与大鼠肠道、小鼠骨骼和人类肠道中的受体极为相似。肾脏中存在受体样结合蛋白这一发现进一步支持了肾脏是1,25(OH)2D3靶器官这一概念。